By crafting authentic, emotional and structured stories, you can inspire your stakeholders to believe in your vision and act on it.
A 68-year-old man presented to the gastroenterology clinic with recurrent melena over 3 months with a history of recurrent spontaneous epistaxis and a familial pattern of similar bleeding among his ...
NotebookLM is very useful for academic, technical, and general research. It doesn’t replace manual reading and fact-finding, but it helps summarize information, answer questions, and reduce the time ...
Understanding temporal dynamics in tissue biology is key to linking transcriptomic snapshots to physiological function. Barkai et al. propose a turnover score derived from gene expression of shed ...
Trump posted the tacky video on Monday, shortly after meeting with Senator Schumer and Minority Leader Jeffries about the potential government shutdown. In the video, the two men can be seen standing ...
More than just a PDF editor, UPDF comes with advanced AI capabilities — including the newly launched AI Deep Research feature — designed to help you work smarter, analyze faster, and create with ...
Discover why Nvidia Corporation is rated a Strong Buy, driven by AI demand and tech leadership. Click for my look at NVDA stock prospects.
The defense secretary went on a crazed rant while putting the entire U.S. military at risk by ordering hundreds of admirals and generals to attend his meeting.
Objectives Structural MRI of the brain is routinely performed on patients referred to memory clinics; however, resulting radiology reports, including volumetric assessments, are conventionally stored ...
Basic research, often termed fundamental, frontier, blue-sky, curiosity-driven—or even useless—is the pursuit of knowledge for its own sake, unshackled by immediate practical applications (Flexner, ...
Aging of the brain is characterized by deleterious processes at various levels including cellular/molecular and structural/functional changes. Many of these processes can be assessed in vivo by means ...
Radiopharmaceutical therapy (RPT) with [177 Lu]Lu-PSMA-617 was approved both by the U.S. Food and Drug Administration and the European Medicines Agency in 2022 for the treatment of patients with ...